Search clinical trials for: patients with multiple myeloma
Total 202208 results
-
University of Heidelberg Medical CenterCompleted
-
National Cancer Institute (NCI)CompletedHematologic NeoplasmsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Secondary...United States
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNeurotoxicity | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Gilead SciencesTerminatedMultiple MyelomaUnited States
-
CelgeneCompleted
-
CelgeneAmalgam RxTerminated
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
Novartis PharmaceuticalsTerminatedMultiple MyelomaUnited States, Germany
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell Myeloma | Myeloproliferative Neoplasm | Recurrent... and other conditionsUnited States
-
Siddhartha GangulyCompleted
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedRefractory Multiple MyelomaSwitzerland
-
Burzynski Research InstituteTerminated
-
National Cancer Institute (NCI)TerminatedMyeloma, Multiple | Myeloma-MultipleUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedAcute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Myelofibrosis | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Hematologic Malignancies | Myeloproliferative SyndromeUnited States
-
Nantes University HospitalActive, not recruiting
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Intergroupe Francophone du MyelomeCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Fondazione EMN Italy OnlusTerminated
-
Sherif S. FaragNational Cancer Institute (NCI)CompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Instituto de Investigacion Sanitaria La FeBristol-Myers SquibbTerminated
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedFatigue | Anemia | Weight Loss | Thrombocytopenia | Fever | Refractory Plasma Cell Myeloma | Lymphadenopathy | Refractory Chronic Lymphocytic Leukemia | Recurrent Plasma Cell Myeloma | Splenomegaly | Recurrent Chronic Lymphocytic Leukemia | Lymphocytosis | Night SweatsUnited States
-
PETHEMA FoundationCompletedRelapsed and Refractory Multiple MyelomaSpain
-
Fred Hutchinson Cancer CenterCompletedPrimary Myelofibrosis | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated... and other conditionsUnited States
-
Massachusetts General HospitalEmory University; University of Rochester; Amgen; University Hospitals Cleveland...UnknownMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Novartis PharmaceuticalsCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Single Umbilical Cord Blood Transplantation | Non-myeloablative ConditioningUnited States
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
University of SouthamptonNIHR Clinical Research Facility, University Hospital Southampton NHS Foundation... and other collaboratorsTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Novartis PharmaceuticalsCompletedBreast Cancer | Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Novartis PharmaceuticalsCompletedMultiple MyelomaFrance, Australia, United States, Spain
-
Novartis PharmaceuticalsCompletedRenal Insufficiency | Multiple MyelomaUnited Kingdom, Spain, United States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Germany, Spain, Singapore
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Novartis PharmaceuticalsCompleted
-
Zealand University HospitalOdense University Hospital; Region of Southern Denmark; Association of Danish... and other collaboratorsCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative Neoplasms | Multiple Myeloma and Malignant Plasma Cell NeoplasmsUnited States